Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 12q15q21 1 Microdeletion Syndrome C4518344
Clinical comparison between 2p13 2 Microdeletion Syndrome and 12q15q21 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
12q15q21 1 Microdeletion Syndrome C4518344
A rare chromosomal deletion affecting a portion of chromosome 12. Presentation varies and may include developmental concerns and medical issues. Treatment addresses specific symptoms with a multidisciplinary approach.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
12q15q21 1 Microdeletion Syndrome C4518344
0-0
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
12q15q21 1 Microdeletion Syndrome C4518344
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
12q15q21 1 Microdeletion Syndrome C4518344
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
12q15q21 1 Microdeletion Syndrome C4518344
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
12q15q21 1 Microdeletion Syndrome C4518344
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
12q15q21 1 Microdeletion Syndrome C4518344
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 12q15q21-1-microdeletion-syndrome-C4518344 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 12q15q21 1 Microdeletion Syndrome C4518344 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Deletion involving 2p13.2 is the defining finding. | Deletion involving 12q15-q21.1 is the defining finding. | High |
| Severity label | Source classifies the condition as severe, but individual effects vary. | Source classifies it as moderate, with variable presentation. | Moderate |
| Developmental concerns | Specific developmental features are not established here. | Developmental concerns may occur, but details are not established. | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Confirmed deletion at 2p13.2
The chromosomal location distinguishes this syndrome from a chromosome 12 deletion.
High
Rare-disease classification is needed
The supplied category is rare disease, although both are genetic chromosomal conditions.
Moderate
Severe congenital presentation is being contextualized
The severe label may guide expectations, but it does not define every patient's course.
Low
Choose 12q15q21 1 Microdeletion Syndrome C4518344 when
Confirmed deletion at 12q15-q21.1
A deletion in this chromosome 12 interval supports the right diagnosis.
High
Developmental concerns accompany a chromosome 12 finding
The source allows developmental concerns, without establishing a specific pattern.
Moderate
Moderate severity is the assigned label
This matches the supplied severity, while individual findings still require review.
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 12q15q21 1 Microdeletion Syndrome C4518344 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss mapped to 2p13.2. | Copy-number loss mapped to 12q15-q21.1. | Locus and breakpoints, not symptoms alone, distinguish the diagnoses. |
| Karyotype | May be normal if the deletion is too small to see. | May also miss a small deletion. | A normal karyotype does not exclude either condition. |
| Locus-specific FISH or targeted assay | Positive only when probes target the relevant 2p13.2 region. | Positive only when probes target the relevant chromosome 12 region. | A targeted test cannot exclude a deletion outside its design. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the source only labels it severe and chronic.
- Factors
- Affected genes, deletion extent, and each person's findings may influence course.
12q15q21 1 Microdeletion Syndrome C4518344
- Outcome
- Long-term outcome is not established; the source labels it moderate and chronic.
- Factors
- Variable developmental and medical issues may influence support needs.
Time frame: Lifelong follow-up is reasonable, but no specific timeline is established.
Prognosis cannot be inferred from severity labels alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Gene-specific effects | Depend on genes within the missing 2p13.2 segment; exact effects are not established here. Depend on genes within 12q15-q21.1; exact effects are not established here. Do not infer a complication solely from the syndrome name. |
| Developmental needs | Possible but not specified by the supplied description. Developmental concerns are mentioned, without a defined severity or domain. Assessment should be individualized. |
| Chronic medical complexity | Described as chronic and severe, without specified organ complications. Described as chronic and moderate, with variable medical issues. Neither description establishes mortality or a uniform complication. |
Patient education highlights
- HighDiagnosis
The diagnosis depends on the chromosomal result and should be explained by a genetics clinician.
- HighVariable features
People with the same deletion label can differ; no single symptom list is established here.
- MediumCare approach
Care is directed at identified needs and may involve multiple specialties.